Search
vTv Therapeutics Inc
VTVTAdd to Watchlist
30.450USD
-0.130-0.42%
Market hours 09/24, 10:08（ET）
119.97MMarket Cap
LossP/E TTM
vTv Therapeutics Inc (VTVT) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to vTv Therapeutics Inc in the past month.
Buy
1 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
55.800USD+79.42%
VTVT Analyst Recommendation Trends
In the current month, VTVT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VTVT average Analyst price target in the last month is 55.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
5
5
5
5
VTVT Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, VTVT EPS is projected to reach -1.168 in FY2026Q3, following reported EPS of -1.052 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.09
-0.10
-0.99
-1.17
-1.19
Actual
-0.57
1.94
-1.05
--
--
Surprise
+47.31%
+2147.20%
-6.26%
--
--
FAQs
What is vTv Therapeutics Inc's price target?
Analysts forecast that vTv Therapeutics Inc's price target is USD 55.80, with the highest forecast at USD 67.00 and the lowest forecast at USD 42.00.
How have vTv Therapeutics IncVTVT's recent earnings per share performed?
The market expectation was USD -1.05, while vTv Therapeutics IncVTVT's earnings per share (EPS) for the previous quarter was USD 1.94. EPS for the next quarter is expected at USD -1.17.
What is the analyst rating for vTv Therapeutics Inc?
Based on the ratings of vTv Therapeutics Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.